Philips Ultrasound Workspace is a holistic, scalable, cardiovascular viewing, analysis and reporting system that enables greater efficiency by giving care teams the flexibility to adopt workflows based on their individual needs. Leveraging AI for speed and diagnostic confidence and capable of analyzing vendor-agnostic data, it offers an agile technology platform, flexible licensing for small- to large-scale organizations, and comprehensive application support. It also incorporates quality assessment capabilities on American Society of Echocardiography (ASE) and Intersocietal Accreditation Commission (IAC) standards. Ultrasound Workspace can be deployed either stand-alone or deeply integrated into PACS and EMR echocardiography reading workflows.

For more information on Philips Ultrasound Workspace and other new cardiology solutions designed to strengthen clinical confidence, build efficiency and help improve cardiac care experiences, visit Philips at ACC 2022 (April 2 - 4, Washington, DC) and follow @PhilipsLiveFrom for #ACC22 updates throughout the event.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries.

Back to HCB News

Health IT Homepage